Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
May. 29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
May. 29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 158B | - | ||
+5.21% | 68.12B | B- | ||
+7.45% | 21.02B | A- | ||
+33.23% | 6.81B | B- | ||
+78.87% | 2.43B | - | C+ | |
-4.23% | 1.8B | - | ||
-2.75% | 1.73B | - | D+ | |
-28.76% | 1.18B | - | B+ | |
-.--% | 653M | - | - | |
+24.66% | 578M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PM Stock
- PMI Stock
- Ratings Philip Morris International, Inc.